<DOC>
	<DOCNO>NCT01354717</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled , three treatment parallel study normal , healthy men woman ( age 45-85 ) actinic keratosis treat face daily two week 5-Fluorouracil Cream 0.5 % , Spear Pharmaceuticals ( Generic ) , Carac® Cream 0.5 % ( Brand ) , Cream Vehicle ( Placebo ) . Actinic keratoses count baseline visit visit four week follow cessation treatment .</brief_summary>
	<brief_title>Bioequivalence Study Generic Fluorouracil 0.5 % Cream 0.5 % Carac® Placebo</brief_title>
	<detailed_description>actinic keratosis</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Men woman presence actinic keratoses Women surgical sterilization postmenopausal ( absence menses least one year ) eligible . Women childbearing potential nonpregnant nonnursing , willing avoid pregnancy course study menstrual cycle follow completion participation study eligible . ( Adequate contraception define regular use , diaphragm condom , IUD condom , systemic contraceptive use least three month prior enrollment study ) . A negative pregnancy test require entry study Able refrain use topical medication facial area treatment period Considered reliable capable understanding responsibility role study Have provide write informed consent History allergy hypersensitivity 5fluorouracil Known dihydropyrimidine dehydrogenase ( DPD ) enzyme deficiency Clinical evidence severe , uncontrolled autoimmune , cardiovascular , gastrointestinal , hematological , hepatic , neurological , pancreatic , pulmonary renal disease Dermatologic condition present face : atopic dermatitis , basal cell carcinoma , eczema , psoriasis , rosacea , squamous cell carcinoma , albinism Positive urine pregnancy test woman childbearing potential Inability use adequate birth control measure woman childbearing potential , define Serious psychological illness Significant history ( within past year ) alcohol drug abuse Participation clinical research study 30 day period precede study initiation Medical history , base clinical judgment investigator , imply unlikelihood successful completion study Treatment actinic keratosis skin cancer previous 28 day follow : topical 5 fluorouracil , cryodestruction ( liquid nitrogen spray ) , curettage ( scrap precancer skin cancer ) , surgical removal skin cancer , photodynamic therapy , surgical excision , topical diclofenac ( Solaraze ) , topical imiquimod ( Aldara ) , topical retinoids use actinic keratosis treatment actinic keratoses Application 1 ) chemical peel , 2 ) dermabrasion , 3 ) laser abrasion , 4 ) PUVA ( psoralen plus ultraviolet A ) therapy , 5 ) UVB therapy face bald scalp within six month prior randomization Use sun lamp sun tan bed booth 2 week prior first application Day 42 visit Any oral ( systemic steroid ) topical corticosteroid within 1 month study entry , except subject chronic low dose corticosteroid le 5 mg daily great 1 year Use within 1 month immunomodulators like interferon , cytotoxic drug Prior treatment systemic 5fluorouracil systemic cancer therapy within 6 month study entry Subjects lesions suspicious squamous cell carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>